ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.

Anja Geisler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.